Uncertainties Lie Ahead For Drugmakers

BMI View: We do not expect South Korea's new Minister of Health and Welfare, Rim Che-min to continue the pursuit of aggressive medicine price cuts, as he appears to be concerned about the impact on the pharmaceutical industry. Nevertheless, the fate of pharmaceutical companies in the country remains uncertain.

To read the full article, please choose one of the following options: